Dr. Padmaja Kumari Rani is a vitreoretinal surgeon and an expert in the management of diabetic retinopathy with 20 years of professional experience. Dr Rani is currently a faculty of Srimati Kanuri Shanthamma Centre for Vitreoretinal diseases, Anant Bajaj Retina Institute, L V Prasad Eye Institute, Hyderabad (India) and Associate Director of Teleophthalmology. She has over 160 peer reviewed publications. She was Key Investigator of Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study (SNDREAMS) group. She managed a District wide Rural Diabetic Retinopathy Project (Nonmydriatic fundus camera based DR screening model) in LV Prasad Eye institute( LVPEI) (2012-2015). She is Key investigator of SMART India (Multicentric DR study)at LVPEI in collaboration with Professor Sobha Sivaprasad, Moorfields Eye Hospital, London. She is passionate in capacity building of Diabetic retinopathy, Retinopathy of Prematurity and telemedicine programs. She is the author of the Sankara Nethralaya Atlas of Vitreoretinal Diseases.
Financial disclosure: Dr. Kumari Rani has/had no affiliation (financial or otherwise) with a commercial organization.
Sessions in which Dr. Padmaja Kumari Rani participates
Saturday 17 June, 2023
Learning Objectives:At the end of this session, participants will be able to:Elucidate the cause and mechanism of DVD.Identity indications of Light adjustable lensXX
Learning ObjectivesAt the end of this session participants will be able to:Describe the impact of AI technologies on eye care Understand the unique aspects of eye health needs in remote populations C...
Learning ObjectivesAt the end of this session participants will be able to:Describe the impact of AI technologies on eye care Understand the unique aspects of eye health needs in remote populationsCompare various models of care for remote populations in low and middle-income countries CanMeds Roles: Professional, Health Advocate
Sessions in which Dr. Padmaja Kumari Rani attends
Saturday 17 June, 2023
Learning Objectives: At the end of this session, participants will be able to: Identify Imaging Signs & Biomarkers for ongoing anti-VEGF treatmentIdentify and review pathognomonic imaging features of Inherited Retinal DiseaseReview unique retinal imaging findings in uncommon retinal conditions